Foclivia Sospensione iniettabile in una siringa Preriempita

Land: Zwitserland

Taal: Italiaans

Bron: Swissmedic (Swiss Agency for Therapeutic Products)

Werkstoffen:

haemagglutininum influenzae A (H5N1), neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14)

Beschikbaar vanaf:

Medius AG

ATC-code:

J07BB02

INN (Algemene Internationale Benaming):

haemagglutininum influenzae A (H5N1), neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14)

farmaceutische vorm:

Sospensione iniettabile in una siringa Preriempita

Samenstelling:

haemagglutininum influenzae A (H5N1) et neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14) 7.5 µg, adjuvans MF59C.1: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acidum citricum monohydricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml.

klasse:

B

Therapeutische categorie:

Vaccini

Therapeutisch gebied:

Pandemico Influenzale Vaccino

Autorisatie-status:

zugelassen

Autorisatie datum:

2018-04-20